MedTrace Logo

Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

NCT06543446 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3290

Last updated 2026-05-12

No results posted yet for this study

Summary

The investigators aim to compare the risk of mortality of Non-implantable carioverter defibrillator (ICD) vs. ICD management in patients with heart failure with reduced ejection fraction (HFrEF).

Conditions

  • Heart Failure With Reduced Ejection Fraction

Interventions

PROCEDURE

ICD implantation

Surgical implant of ICD device

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • University of Rochester

    lead OTHER

Principal Investigators

  • Ilan Goldenberg, MD · Univ of Rochester Medical Center, Clinical Cardiovascular Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-04
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06543446 on ClinicalTrials.gov